DE2536349A1 - Neue pharmazeutische mittel - Google Patents

Neue pharmazeutische mittel

Info

Publication number
DE2536349A1
DE2536349A1 DE19752536349 DE2536349A DE2536349A1 DE 2536349 A1 DE2536349 A1 DE 2536349A1 DE 19752536349 DE19752536349 DE 19752536349 DE 2536349 A DE2536349 A DE 2536349A DE 2536349 A1 DE2536349 A1 DE 2536349A1
Authority
DE
Germany
Prior art keywords
pharmaceutical agent
agent according
tert
alkyl
diuretic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19752536349
Other languages
German (de)
English (en)
Inventor
Charles Samuel Sweet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2536349A1 publication Critical patent/DE2536349A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19752536349 1974-08-16 1975-08-14 Neue pharmazeutische mittel Ceased DE2536349A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49796174A 1974-08-16 1974-08-16
US55437375A 1975-03-03 1975-03-03

Publications (1)

Publication Number Publication Date
DE2536349A1 true DE2536349A1 (de) 1976-02-26

Family

ID=27052662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752536349 Ceased DE2536349A1 (de) 1974-08-16 1975-08-14 Neue pharmazeutische mittel

Country Status (10)

Country Link
AU (1) AU505455B2 (US07118763-20061010-C00002.png)
CA (1) CA1044141A (US07118763-20061010-C00002.png)
CY (1) CY978A (US07118763-20061010-C00002.png)
DE (1) DE2536349A1 (US07118763-20061010-C00002.png)
FR (1) FR2281757A1 (US07118763-20061010-C00002.png)
GB (1) GB1495034A (US07118763-20061010-C00002.png)
HK (1) HK73178A (US07118763-20061010-C00002.png)
KE (1) KE2903A (US07118763-20061010-C00002.png)
MY (1) MY7900033A (US07118763-20061010-C00002.png)
NL (1) NL7508856A (US07118763-20061010-C00002.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192673A (en) * 1979-02-02 1984-07-06 Merck & Co Inc Ophthalmic compositions for lowering intraocular pressure
IE50901B1 (en) * 1980-03-04 1986-08-06 Merck & Co Inc Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis

Also Published As

Publication number Publication date
AU8371375A (en) 1977-02-10
CY978A (en) 1979-03-23
FR2281757A1 (fr) 1976-03-12
CA1044141A (en) 1978-12-12
FR2281757B1 (US07118763-20061010-C00002.png) 1980-04-11
NL7508856A (nl) 1976-02-18
KE2903A (en) 1978-12-01
GB1495034A (en) 1977-12-14
AU505455B2 (en) 1979-11-22
HK73178A (en) 1978-12-22
MY7900033A (en) 1979-12-31

Similar Documents

Publication Publication Date Title
DE4117371A1 (de) Antimykotische mittel, die phenylessigsaeurederivate enthalten
DE2523998A1 (de) Pharmazeutische zubereitung fuer die behandlung der schizophrenie
DE69632854T2 (de) Schutzmittel für Organe und Gewebe
DE2350222A1 (de) Pharmazeutische mittel, die ein 4-aryl-2-(3-pyridyl)-thiazol enthalten, und ihre anwendung
EP0224810B1 (de) Antihypertensives Kombinationspräparat
DE2854316C2 (US07118763-20061010-C00002.png)
DE2536349A1 (de) Neue pharmazeutische mittel
DE3874900T2 (de) Wirkstoff mit die nierenfunktion verbesserndem und diuretischem effekt und verwendung eines darin enthaltenen benzothiazepin-derivates.
DE2034640C3 (de) l-p-(7-Trifluormethyl-4-chinolyl) -amino-benzoyl-piperazine, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung von Bluthochdruck
EP0013252B1 (de) Mittel zur Senkung der Herzfrequenz
US4178374A (en) Novel pharmaceutical compositions of β-blockers with diuretics
DE2449088A1 (de) Stoffzusammensetzung fuer warmbluetlern zur bekaempfung von inneren parasiten
US4238485A (en) Novel pharmaceutical compositions
EP0334164B1 (de) Antihypertensives Kombinationspräparat
EP0315861B1 (de) Antimycotische Zusammensetzungen aus Nikkomycin-Verbindungen und antimycotischem Azol
DE2742059A1 (de) Halogenierte sulfonanilide als anthelmintika
DE2340632C2 (de) Verwendung von 2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazol oder von dessen Salzen bei der unterstützenden Behandlung zur Rückbildung und Linderung von Neoplasmen
DE2645646A1 (de) Zusammensetzung aus beta-blockern, indanonderivaten und gegebenenfalls amilorid
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie
DE1617286C (de) Arzneimittel auf der Basis von 4-Methyl-5-(2-chloräthyl)-thiazol
DE2810051A1 (de) Zubereitung fuer die behandlung von asthma
DE2808572C2 (de) Hämostatisches Mittel
DE2823268A1 (de) Blutdrucksenkendes mittel
DD283931A5 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von herzrhythmusstoerungen
EP1474134B1 (de) Kombinationspräparat des natrium-wasserstoff-austausch-inhibitors cariporide mit ramipril zur verhinderung bzw zur hemmung der herzinsuffizienz

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ABITZ, W., DIPL.-ING.DR.-ING. MORF, D., DR., PAT.-

8131 Rejection